| 臺大學術典藏 |
2022-01-24T09:32:06Z |
Pegylated interferon-α-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: A multicenter, randomized controlled trial
|
Liu C.-H.; CHUN-JEN LIU; Lin C.-.; Liang C.-C.; Hsu S.-J.; Yang S.-S.; Hsu C.-S.; Tseng T.-C.; Wang C.-C.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:05Z |
Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels
|
Tseng T.-C.; CHUN-JEN LIU; Wang C.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:05Z |
Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus
|
Huang Y.-W.; Hu C.-Y.; Chen C.-L.; Liao Y.-T.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Yang S.-S.; Hu J.-T.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:04Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh T.-H.; Tseng T.-C.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Hsieh H.-L.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:04Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU; Wang C.-C.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection
|
CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Liu C.-H.; Chen C.-L.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tsai H.-B.; Hung P.-H.; Hsu S.-J.; Chen S.-L.; Lin J.-W.; Lai M.-Y.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:02Z |
Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy
|
Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:01Z |
Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy
|
Tseng T.-C.; CHUN-JEN LIU; Hsieh S.-C.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:01Z |
Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B
|
CHUN-JEN LIU; Jeng Y.-M.; Chen C.-L.; Cheng H.-R.; Chen P.-J.; Chen T.-C.; Liu C.-H.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:00Z |
Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:32:00Z |
The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Hsu S.-J.; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:59Z |
Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection
|
Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; CHUN-JEN LIU; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:59Z |
Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan
|
Huang Y.-W.; Liao Y.-T.; Chen W.; Chen C.-L.; Hu J.-T.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Yang S.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:59Z |
Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
|
Huang Y.-W.; Chayama K.; Tsuge M.; Takahashi S.; Hatakeyama T.; Abe H.; Hu J.-T.; CHUN-JEN LIU; Lai M.-Y.; Chen D.-S.; Yang S.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:59Z |
Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B
|
Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:58Z |
Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Lin J.-W.; Chen S.-I.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:58Z |
HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses
|
Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; Su T.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; CHUN-JEN LIU; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:31:57Z |
Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan
|
Mah Y.-H.; Hsu C.-S.; Liu C.-H.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:56Z |
Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients
|
Liu C.-H.; Liang C.-C.; Huang K.-W.; CHUN-JEN LIU; Chen S.-I.; Lin J.-W.; Hung P.-H.; Tsai H.-B.; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:55Z |
Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy
|
Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; CHUN-JEN LIU; Lai M.-Y.; Chen P.-J.; Kao J.-H.; Chen D.-S. |
| 臺大學術典藏 |
2022-01-24T09:31:52Z |
Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission
|
Lin C.-L.; Tseng T.-C.; Su T.-H.; CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-12-02T02:18:10Z |
Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report
|
Lynn, T C; Hsieh, R P; Lin, K T; MING-CHING SHEN; Chen, D S; CHING-HUA WANG; CHEN-HSUAN LIU; Wang, J H; Lai, M Y; Liou, M F |
| 臺大學術典藏 |
2021-12-02T02:10:20Z |
Prevalence of anti-oncogenic virus antibodies in patients with malignancies, hemophilia and systemic lupus erythematosus
|
Lin, K T; Liu, M F; Hsieh, R P; Lynn, T C; MING-CHING SHEN; Wang, J H; YONG-CHANG CHEN; Lai, M Y; Chen, D S; CHEN-HSUAN LIU |
| 臺大學術典藏 |
2021-12-01T08:25:25Z |
Portal, splenic, and superior mesenteric venous thrombosis associated with essential thrombocythemia: Report of a case
|
Chen G.-J.; Lee C.-Z.; Lai M.-Y.; MING-CHING SHEN; Chen D.-S. |
